Sangamo Therapeutics Inc (SGMO)

Jun 03, 2025

H.C. Wainwright Maintains Buy Rating on Sangamo Therapeutics (SGMO) - MSN

Jun 03, 2025

Jun 01, 2025

10 Promising Biotech Stocks to Invest in (June 2025) - Securities.io

Jun 01, 2025

May 30, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 30, 2025

May 29, 2025

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering - Zenopa

May 29, 2025

May 27, 2025

Sangamo Therapeutics’ SWOT analysis: genomic medicine firm faces cash crunch - Investing.com

May 27, 2025

May 26, 2025

Lazard Asset Management LLC Takes Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

May 26, 2025

May 24, 2025

Captrust Financial Advisors Makes New $30,000 Investment in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

May 24, 2025

May 22, 2025

StockNews.com Initiates Coverage on Sangamo Therapeutics (NASDAQ:SGMO) - Defense World

May 22, 2025

May 16, 2025

Barclays Issues Pessimistic Forecast for Sangamo Therapeutics (NASDAQ:SGMO) Stock Price - Defense World

May 16, 2025

May 15, 2025

Sangamo Biosciences’ Earnings Call: Progress Amid Challenges - TipRanks

May 15, 2025

May 14, 2025

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 14, 2025

May 14, 2025

Barclays Updates Price Target for Sangamo Therapeutics (SGMO) | SGMO Stock News - GuruFocus

May 14, 2025

May 14, 2025

Sangamo (SGMO) Price Target Reduced by Barclays | SGMO Stock New - GuruFocus

May 14, 2025

May 14, 2025

Sangamo Biosciences Announces $23 Million Share Offering - TipRanks

May 14, 2025

May 13, 2025

Sangamo Therapeutics (SGMO) Projects 2025 Operating Expenses Ami - GuruFocus

May 13, 2025

May 13, 2025

Sangamo Therapeutics Inc (SGMO) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo Finance

May 13, 2025

May 13, 2025

Sangamo Therapeutics Inc (SGMO) Q1 2025 Earnings Call Highlights - GuruFocus

May 13, 2025

May 13, 2025

Sangamo Therapeutics prices $23M securities offering - MSN

May 13, 2025

May 13, 2025

Market Setbacks: Major Stocks Face Financial Hurdles - Finimize

May 13, 2025

May 13, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 13, 2025

Sangamo Therapeutics (SGMO) Announces $23M Capital Raise - GuruFocus

May 13, 2025

May 13, 2025

Sangamo Therapeutics (SGMO) Reports First Quarter Revenue Below - GuruFocus

May 13, 2025

May 13, 2025

Sangamo Therapeutics (SGMO) Q1 Earnings Miss Expectations - GuruFocus

May 13, 2025

May 13, 2025

Transcript : Sangamo Therapeutics, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com

May 13, 2025

May 13, 2025

Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day - BioSpace

May 13, 2025

May 13, 2025

Sangamo Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 13, 2025

May 12, 2025

Sangamo Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025

May 12, 2025

Earnings call transcript: Sangamo Therapeutics faces stock drop after Q1 2025 call - Investing.com Nigeria

May 12, 2025

May 12, 2025

Sangamo Therapeutics Reports Recent Business Highlights and Firs - GuruFocus

May 12, 2025

May 12, 2025

Sangamo Therapeutics (SGMO) Reports First Quarter Revenue Below Expectations | SGMO Stock News - GuruFocus

May 12, 2025

May 12, 2025

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwri - GuruFocus

May 12, 2025

May 12, 2025

Sangamo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

May 12, 2025

Sangamo Therapeutics, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:SGMO) - Seeking Alpha

May 12, 2025

May 12, 2025

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results | SGMO Stock News - GuruFocus

May 12, 2025

May 12, 2025

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results - BioSpace

May 12, 2025

May 12, 2025

Sangamo: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025

May 12, 2025

Sangamo Therapeutics Announces First Quarter 2025 Earnings Call - Zenopa

May 12, 2025

May 12, 2025

Sangamo Therapeutics (SGMO) Anticipates Q1 Earnings Release - GuruFocus

May 12, 2025

May 08, 2025

Sangamo hits milestone toward accelerated approval for ST-920 - Fabry Disease News

May 08, 2025

May 07, 2025

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease - BioSpace

May 07, 2025

May 06, 2025

Sangamo Biosciences Receives Nasdaq Deficiency Notice - TipRanks

May 06, 2025